Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
Thursday at 6 on WRAL: She says her Maytag oven exploded while she was asleep! How 5 On Your Side helped her out when the manufacturer wouldnât!
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Edgewise Therapeutics Inc
(NQ:
EWTX
)
33.32
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edgewise Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Edgewise Therapeutics Begins Dosing First-in-Human Phase 1 Trial of EDG-7500, its Lead Clinical Candidate for Hypertrophic Cardiomyopathy (HCM) and Other Serious Diseases of Cardiac Diastolic Dysfunction
September 14, 2023
From
Edgewise Therapeutics
Via
Business Wire
Where Edgewise Therapeutics Stands With Analysts
August 16, 2023
Via
Benzinga
Edgewise Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
August 10, 2023
From
Edgewise Therapeutics
Via
Business Wire
Analyst Ratings for Edgewise Therapeutics
June 27, 2023
Via
Benzinga
Edgewise Therapeutics: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 27, 2023
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.
Via
Benzinga
CIRCOR International, Enovix, Edgewise Therapeutics And Other Big Stocks Moving Higher On Tuesday
June 27, 2023
U.S. stocks traded higher, with the Dow Joned gaining around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Edgewise Therapeutics Touts Positive Data From Investigational Drug In Form Of Muscular Dystrophy
June 27, 2023
Edgewise Therapeutics Inc (NASDAQ: EWTX) released 12-month topline results from the ARCH study, an open-label, single-center study assessing EDG-5506 in adults with
Via
Benzinga
Edgewise Therapeutics Announces Positive 12-Month Topline Results from the ARCH Open Label Study of EDG-5506 in Adults with Becker Muscular Dystrophy (BMD)
June 26, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics to Present at the Goldman Sachs Global Healthcare Conference
June 06, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
May 11, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics to Present at Upcoming Investor Conferences
May 02, 2023
From
Edgewise Therapeutics
Via
Business Wire
Flexing On Muscular Dystrophy, Analyst Expects Almost 200% Upside For Edgewise Therapeutics
May 01, 2023
Truist initiated coverage on Edgewise Therapeutics Inc (NASDAQ: EWTX) with a Buy rating and a
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023
May 01, 2023
Via
Benzinga
Xerox, Hubbell, Spotify And Other Big Stocks Moving Higher On Tuesday
April 25, 2023
U.S. stocks traded lower, with the Nasdaq Composite dropping around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis
April 19, 2023
Tiziana Life Sciences (NASDAQ: TLSA), a London-based biotechnology company, is developing a first-in-class drug, Foralumab. Foralumab is the only fully human anti-CD3 monoclonal antibody (mAb) at the...
Via
Benzinga
Edgewise Therapeutics Announces Journal of Clinical Investigation Publication of Key Preclinical Data Linking Modulation of Fast Skeletal Muscle Contraction to Protection of Skeletal Muscle in Models of Duchenne Muscular Dystrophy (DMD)
March 30, 2023
From
Edgewise Therapeutics
Via
Business Wire
Top 5 Health Care Stocks That Preparing To Pump This Quarter
March 29, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Edgewise Therapeutics to Present at the Stifel 2023 CNS Days on March 28, 2023
March 21, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics to Present on EDG-5506 for Becker and Duchenne Muscular Dystrophy (BMD, DMD) at the 2023 Annual MDA Clinical and Scientific Conference
March 14, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics Appoints Industry Veteran Jonathan C. Fox, M.D., Ph.D., FACC to its Board of Directors
March 06, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics to Present at the Cowen 43rd Annual Health Care Conference on March 8, 2023
March 01, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics Announces Upcoming Presentation at the American College of Cardiology's 72nd Annual Scientific Session Together with World Congress of Cardiology
February 28, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
February 23, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics to Present at the SVB Securities Global Biopharma Conference on February 14, 2023
February 07, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023
January 04, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics to Showcase Novel Cardiac Program at Virtual Investor Event on Tuesday, January 3, 2023
December 21, 2022
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics Appoints Marc Semigran, M.D., As Chief Development Officer
December 20, 2022
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics to Present at Upcoming Investor Conferences
November 09, 2022
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics Reports Third Quarter 2022 Financial Results
November 03, 2022
From
Edgewise Therapeutics
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.